CAR macrophages could contribute to shifting the TME towards tumor rejection by releasing inflammatory cytokines such as TNF, IL-6, IFNγ, and IL-12 [89,98,99], by promoting T cell recruitment and function, and tumor growth suppression [99]. Here, IFNG is linked to neoplasm.